Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24216,887,1.62 [1.35-1.94],1.401265176235077e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,24454,264,1.90 [1.45-2.49],3.896125796135572e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23755,2406,1.55 [1.37-1.74],3.1622798627830897e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23979,1817,1.50 [1.31-1.72],8.813412305308319e-09
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24271,862,1.36 [1.12-1.64],0.0018499784770823
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23339,562,2.19 [1.78-2.69],1.497242324249069e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22547,530,2.23 [1.77-2.81],1.4831106919164225e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22776,150,2.71 [1.89-3.91],7.585094826288998e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18182,1060,1.54 [1.29-1.85],2.957386010022394e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22572,250,1.62 [1.13-2.34],0.0091724766094759
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24417,1008,1.40 [1.17-1.67],0.0002083274976293
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,24512,322,1.83 [1.41-2.37],5.757908832997722e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23870,541,1.92 [1.57-2.34],2.4506588330116767e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24458,616,2.08 [1.70-2.55],1.956868382105926e-12
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24385,543,2.20 [1.78-2.71],1.595927510153364e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23476,67,2.18 [1.31-3.64],0.0028716877791476
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24526,46,2.43 [1.45-4.08],0.0007934319039662
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21187,31,3.93 [2.56-6.05],4.0433375191514366e-10
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21190,34,2.34 [1.24-4.44],0.0088008747262204
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,21184,28,3.36 [2.10-5.40],4.99703207068407e-07
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21201,45,2.89 [1.69-4.95],0.0001119463778631
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21208,52,2.59 [1.48-4.53],0.0008895580639942
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21211,55,2.32 [1.38-3.89],0.0014242032761133
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21260,104,2.02 [1.31-3.13],0.0015995155025241
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21216,60,2.15 [1.26-3.67],0.0047378780936712
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24300,268,1.88 [1.40-2.51],2.180265149415149e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23839,1961,1.53 [1.34-1.74],1.2270351559806856e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24239,27,2.94 [1.71-5.04],9.3735647226822e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24156,891,1.57 [1.30-1.89],3.293416040619705e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24156,891,1.57 [1.30-1.89],3.293416040619705e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24306,803,1.60 [1.33-1.93],9.325808676509412e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24380,168,2.49 [1.90-3.27],3.473835301052433e-11
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24482,61,2.30 [1.43-3.70],0.0006369318662905
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24356,144,2.42 [1.79-3.28],1.1059813522501789e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21072,180,2.90 [2.01-4.17],9.75787223401671e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24186,1470,1.25 [1.07-1.46],0.0042953269058775
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21988,1429,1.26 [1.08-1.47],0.0036009070232127
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23100,52,2.48 [1.35-4.56],0.0033930054080987
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23015,2123,1.45 [1.27-1.65],2.998629559207194e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20927,35,4.72 [2.84-7.85],2.290498394480833e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24177,1129,1.32 [1.11-1.58],0.0014870781331547
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21003,111,3.28 [2.35-4.59],3.5362638171260232e-12
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21028,136,1.93 [1.18-3.15],0.0083942341265724
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20947,55,3.38 [1.83-6.25],9.810838927038782e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21157,265,1.84 [1.29-2.62],0.0008001004154761
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21167,275,1.79 [1.27-2.52],0.0009317569741891
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23930,3038,1.40 [1.26-1.57],1.250470069212852e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21685,793,2.01 [1.65-2.46],4.444193245689618e-12
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24545,109,2.05 [1.38-3.04],0.0003524243188083
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22955,108,2.60 [1.82-3.73],1.8634358562660215e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24188,1341,2.02 [1.76-2.31],1.6606709211216478e-23
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21253,361,1.71 [1.26-2.32],0.0005844041851815
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23884,48,2.96 [1.67-5.26],0.0002099066153544
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,23424,710,1.57 [1.26-1.95],5.584595618591009e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23929,93,2.52 [1.59-4.01],9.31283927643977e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23932,96,1.93 [1.21-3.09],0.0060191533462115
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17428,810,1.62 [1.32-1.99],3.213623986868841e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiac arrest,16715,97,2.08 [1.32-3.30],0.001733106518663
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,22656,476,1.55 [1.20-2.02],0.0009766078415823
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23902,1198,1.65 [1.40-1.94],1.890474226393981e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22811,5399,1.30 [1.19-1.41],5.24469586852615e-10
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24446,461,1.90 [1.50-2.41],9.19310809783516e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,23319,4393,1.26 [1.15-1.38],4.390603468017545e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23327,4401,1.26 [1.15-1.38],6.588296683398549e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24397,48,4.07 [2.88-5.76],1.9873627106865195e-15
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19007,81,2.58 [1.76-3.77],9.922313081299826e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,24463,606,1.38 [1.10-1.74],0.0061163958910501
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24053,1339,1.52 [1.30-1.78],2.503996142993918e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24329,539,1.53 [1.19-1.95],0.0007625478920963
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23153,439,1.67 [1.28-2.18],0.0001596324167065
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24540,185,1.69 [1.14-2.51],0.0091533791537259
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23968,132,1.93 [1.33-2.78],0.000471628590155
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22704,524,1.66 [1.31-2.12],3.580706730181776e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23898,41,3.28 [2.24-4.80],1.0144248572325122e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24143,307,1.71 [1.31-2.24],9.418791606711488e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24145,139,2.29 [1.63-3.22],1.5863751404034204e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23996,182,1.69 [1.18-2.43],0.0043556392346717
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24516,285,1.86 [1.39-2.49],3.1210392407259845e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22331,151,1.84 [1.19-2.84],0.0057180229906806
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24142,136,2.30 [1.62-3.25],2.737271199967664e-06
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,23876,3272,1.17 [1.05-1.30],0.0037259713852479
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22105,1501,1.29 [1.10-1.50],0.0011551281075696
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24491,202,1.94 [1.35-2.80],0.0003410585295666
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,23454,518,1.45 [1.12-1.89],0.0050059075089925
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,24334,449,1.44 [1.09-1.89],0.0099875374028345
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24320,31,3.44 [2.12-5.57],5.768337770908417e-07
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24477,171,1.98 [1.32-2.96],0.0009680073591102
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24448,554,1.47 [1.15-1.88],0.0021685788053268
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24517,186,1.86 [1.26-2.74],0.0016230470548311
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24390,59,2.43 [1.41-4.20],0.0014794117743311
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24366,35,2.62 [1.29-5.31],0.0074019507301366
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24203,112,2.01 [1.31-3.07],0.0013142564075015
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19486,1574,1.25 [1.07-1.46],0.004613602882343
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19589,1543,1.23 [1.05-1.44],0.0086560571433399
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24303,85,2.21 [1.55-3.16],1.3455795471315196e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23383,50,3.24 [1.88-5.60],2.500364942303469e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bronchiectasis,21831,159,1.91 [1.32-2.76],0.0006368158932798
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23772,2100,1.28 [1.13-1.45],0.0001354420418545
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24464,645,1.40 [1.13-1.72],0.0018192152452377
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22828,3787,1.27 [1.15-1.40],1.2520424420600077e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,24280,461,1.45 [1.16-1.81],0.0011513417187235
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Emphysema,21840,168,1.54 [1.11-2.12],0.009033071805873
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24392,1059,1.67 [1.41-1.99],3.316119553335834e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24547,137,1.84 [1.21-2.79],0.0040784068397169
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24359,566,1.65 [1.32-2.05],7.434235183584569e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,24390,1116,1.60 [1.37-1.87],4.291045884628903e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,23307,33,3.01 [1.98-4.58],2.2966433377881625e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24500,181,2.31 [1.68-3.18],2.680748351675603e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24479,760,1.53 [1.26-1.86],1.677291490396454e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,23810,536,1.93 [1.58-2.35],1.0565891273983164e-10
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24204,871,1.68 [1.39-2.03],6.608082081864296e-08
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24530,120,1.91 [1.26-2.87],0.0020526606957862
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,24355,36,4.13 [2.94-5.80],2.9464412502976825e-16
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24339,546,1.69 [1.36-2.10],2.53211865459758e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23868,77,2.40 [1.69-3.40],9.354978961498576e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23015,49,3.06 [2.02-4.62],1.1543308998418189e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24191,49,3.07 [2.03-4.66],1.233048846851374e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,19787,224,1.82 [1.32-2.49],0.0002250481890635
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,23002,36,2.39 [1.52-3.76],0.0001496855247544
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24424,75,3.56 [2.64-4.80],6.917860327449385e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,23276,98,2.25 [1.47-3.45],0.0001880288162868
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,24357,1027,1.30 [1.09-1.56],0.0044973906695262
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,24446,655,1.94 [1.62-2.32],4.724782564109046e-13
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24476,386,1.46 [1.10-1.93],0.0084760540187027
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24302,1124,1.30 [1.09-1.55],0.0033046897051604
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24096,1130,1.30 [1.09-1.55],0.003033909389966
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23884,93,3.28 [2.48-4.34],8.889338050769241e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19993,7130,1.11 [1.03-1.19],0.0044270602508915
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23836,45,2.91 [1.86-4.53],2.490553091276429e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23296,118,1.97 [1.28-3.03],0.0019025558773748
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24529,340,1.94 [1.51-2.49],2.761527657400661e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23141,175,1.77 [1.21-2.59],0.0031988020235899
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,24318,527,1.96 [1.61-2.40],5.4084395293929615e-11
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23730,152,1.77 [1.24-2.52],0.0016711183868765
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19818,1072,1.32 [1.10-1.57],0.0022957377624444
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23863,72,2.76 [1.87-4.08],3.769887199499602e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,23243,135,2.01 [1.38-2.93],0.0002767259728899
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23225,117,2.01 [1.35-2.97],0.0005110339876576
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23977,491,1.50 [1.15-1.95],0.002509592285758
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24465,352,1.50 [1.12-1.99],0.0058128423834474
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24153,40,2.12 [1.20-3.73],0.0094167327572103
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23251,2297,1.19 [1.05-1.35],0.0058529038470137
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24196,710,1.38 [1.12-1.72],0.0029052956788413
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23158,55,2.28 [1.48-3.54],0.000206897348938
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24167,54,2.13 [1.30-3.49],0.0026832548109142
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23219,116,1.88 [1.22-2.90],0.004480542318572
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21753,356,1.51 [1.13-2.02],0.0057755707615068
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24227,191,2.16 [1.60-2.91],4.148868206433962e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24486,45,2.27 [1.32-3.93],0.0032266507517736
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24541,37,2.36 [1.25-4.46],0.0082399857650577
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24115,79,2.50 [1.75-3.58],5.233798395740611e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24181,145,2.34 [1.80-3.05],2.546214960854888e-10
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24089,753,1.91 [1.59-2.28],1.8594992404758104e-12
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23902,566,1.82 [1.46-2.27],7.699560829991404e-08
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10284,385,0.63 [0.45-0.87],0.0049937974765477
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24431,59,2.74 [1.80-4.19],3.0294488005632898e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11153,1254,0.75 [0.63-0.89],0.0013564253771746
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24507,267,1.57 [1.11-2.21],0.0099901046532965
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23416,1002,1.34 [1.12-1.61],0.0012666438247498
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13140,109,1.79 [1.15-2.77],0.0094613072512826
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24413,41,2.29 [1.24-4.21],0.007742840550925
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24392,1333,1.74 [1.51-2.01],3.2700538363000947e-14
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23184,125,2.21 [1.59-3.06],2.0445688683252988e-06
